Drugs / MSB-CAR001
last change Aug 2017 re-read 2 minutes ago

MSB-CAR001

Cell therapy

Developed for
osteoarthritis
Investigated by
Mesoblast, Inc.

Trials 1 · a red edge is where a trial was stopped

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01088191 Mar 2009 → Nov 2013 osteoarthritis Mesoblast, Inc. Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as MSB-CAR001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01088191
Modality Cell therapy “single intra-articular injection of allogeneic human mesenchymal precursor cells (MPCs)” PMID 28768528 Aug 2017
Route Other “single intra-articular injection of 75 million allogeneic MPCs suspended in hyaluronan (HA)” PMID 28768528 Aug 2017